Business Description
Lionco Pharmaceutical Group Co Ltd
ISIN : CNE1000022R8
Share Class Description:
SHSE:603669: Class ACompare
Compare
Traded in other countries / regions
603669.China IPO Date
2015-05-28Description
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.26 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | -2.77 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.11 | |||||
| Beneish M-Score | -2.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -40.8 | |||||
| 3-Year Book Growth Rate | -14.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.89 | |||||
| 9-Day RSI | 28.32 | |||||
| 14-Day RSI | 35.5 | |||||
| 6-1 Month Momentum % | 25.85 | |||||
| 12-1 Month Momentum % | 9.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.64 | |||||
| Quick Ratio | 4.94 | |||||
| Cash Ratio | 3.79 | |||||
| Days Inventory | 131.25 | |||||
| Days Sales Outstanding | 85.96 | |||||
| Days Payable | 169.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | 4.98 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.27 | |||||
| Operating Margin % | -31.9 | |||||
| Net Margin % | -36.73 | |||||
| FCF Margin % | -33.15 | |||||
| ROE % | -11.01 | |||||
| ROA % | -6.73 | |||||
| ROIC % | -10.27 | |||||
| ROC (Joel Greenblatt) % | -17.56 | |||||
| ROCE % | -7.13 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 42.54 | |||||
| PS Ratio | 13.07 | |||||
| PB Ratio | 4.65 | |||||
| Price-to-Tangible-Book | 5.32 | |||||
| EV-to-EBIT | -40.12 | |||||
| EV-to-EBITDA | -40.12 | |||||
| EV-to-Revenue | 13.83 | |||||
| EV-to-FCF | -43.69 | |||||
| Price-to-Projected-FCF | 4.16 | |||||
| Price-to-Net-Current-Asset-Value | 27.65 | |||||
| Earnings Yield (Greenblatt) % | -2.49 | |||||
| FCF Yield % | -2.3 | |||||
| Forward Rate of Return (Yacktman) % | -15.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lionco Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 277.197 | ||
| EPS (TTM) (Â¥) | -0.15 | ||
| Beta | 1.08 | ||
| Volatility % | 39.77 | ||
| 14-Day RSI | 35.5 | ||
| 14-Day ATR (Â¥) | 0.463665 | ||
| 20-Day SMA (Â¥) | 7.1645 | ||
| 12-1 Month Momentum % | 9.28 | ||
| 52-Week Range (Â¥) | 2.94 - 9.54 | ||
| Shares Outstanding (Mil) | 721.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lionco Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lionco Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lionco Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Lionco Pharmaceutical Group Co Ltd(SHSE:603669)'s stock price today?
The current price of SHSE:603669 is ¥5.53. The 52 week high of SHSE:603669 is ¥9.54 and 52 week low is ¥2.94.
When is next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669)?
The next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is .
Does Lionco Pharmaceutical Group Co Ltd(SHSE:603669) pay dividends? If so, how much?
Lionco Pharmaceutical Group Co Ltd(SHSE:603669) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers